| Literature DB >> 32491988 |
Duk L Na1,2,3,4,5, Jee Hyun Choi6, Ko Woon Kim7,8,9, Sung Yun Lee10,6, Jongdoo Choi1,2, Juhee Chin1,2, Byung Hwa Lee1,2.
Abstract
BACKGROUND: The Rey-Osterrieth Complex Figure Test (RCFT) is a neuropsychological test that is widely used to assess visual memory and visuoconstructional deficits in patients with cognitive impairment, including Alzheimer disease (AD). Patients with AD have an increased tendency for exhibiting extraordinary behaviors in the RCFT for selecting the drawing area, organizing the figure, and deciding the order of images, among other activities. However, the conventional scoring system based on pen and paper has a limited ability to reflect these detailed behaviors.Entities:
Keywords: Rey-Osterrieth Complex Figure; alzheimer disease; copying process; digital biomarkers
Mesh:
Year: 2020 PMID: 32491988 PMCID: PMC7450382 DOI: 10.2196/18136
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1The simplified Rey-Osterrieth Complex Figure Test (RCFT). (A) The simplified RCFT consists of 4 global and 4 local components. (B) The simplified RCFT is shown on a tablet (size: 12 in; resolution: 2160 × 1440; Samsung Galaxy Book 12, Samsung Electronics) with a screen width of 162 mm and a screen height of 258 mm. The texts indicated in blue were not presented to the participants during testing.
Figure 2Pen stroke analysis. Clinical interpretation of copying performance in the Rey-Osterrieth Complex Figure Test (RCFT) was partly based on how an individual draws the image based on consecutive line creations. The number, length, and speed of strokes were analyzed. (A) Long (blue)/short (red) strokes are classified by k-means clustering; (B-D) number of strokes; (E-F) length of strokes; (G-I) speed of strokes. One and two asterisks show significant differences at P<.05 and P<.01 levels, respectively. EOAD: early-onset Alzheimer disease; LOAD: late-onset Alzheimer disease; NC: normal control.
Figure 3Spatial arrangement. (A) We defined the bounded area that contains the whole drawing as the whole area (blue box) and a boundary that contains only the area inside the skeleton rectangle as the skeleton area (red box). (B) An example of the ratio of input in perceptual space: input (blue)/total input (blue + red). (C-D) Center of the whole area. (E-F) Center of mass of the whole area. (G-H) Top and bottom edge of the whole area. (I-J) Top and bottom edges of the skeletal area. (K) Closing-in phenomenon. One, two, and three asterisks show significant differences at P<.05, P<.01, and P<.001 levels, respectively. EOAD: early-onset Alzheimer disease; LOAD: late-onset Alzheimer disease; NC: normal control; RCFT: Rey-Osterrieth Complex Figure Test.
Figure 4Shape similarity between the target and the pictures drawn by the participants. (A) The Pearson correlation coefficient was used to assess cross-correlation for all possible overlap. (B). We applied 2D cross-correlation analysis and calculated its coefficient and shift in space. (C) For both AD groups, pattern matching was significantly poorer than that of the normal control (NC) group (pairwise Mann-Whitney U test: P=.004 for early-onset Alzheimer disease [EOAD] vs NCs and P=.002 for late-onset Alzheimer disease [LOAD] vs NCs). There was no statistical significance between the EOAD and LOAD groups (P=.86). (D) Although the amount of difference was reduced, the similarity was significantly lower for the LOAD group even after rescaling the image size (P=.04). There was no statistical significance for the EOAD group even after adjusting for image size. One and two asterisks show significant differences at P<.05 and P<.01 levels, respectively. RCFT: Rey-Osterrieth Complex Figure Test.
Clinical characteristics.
| Demographics and cognitive profiles | NCa (n=17) | EOADb (n=17) | LOADc (n=21) | Post hoc Bonferroni test ( | |||
|
|
|
|
| NC vs EOAD | NC vs LOAD | EOAD vs LOAD | |
| Age (years), n (IQR) | 73 (65.5-77.0) | 65 (58.5-68.0) | 78 (74.0-81.5) |
|
|
| |
|
| |||||||
|
| Female:male | 8:9 | 8:9 | 8:13 | >.99 |
| >.99 |
| Education (years), n (IQR) | 16 (10.5-16.0) | 12 (9.0-13.0) | 12 (11.0-16.0) | .12 | .36 | >.99 | |
| APOE4e carrierf, n (%) | 0g (0) | 10h/16 (63) | 9i/20 (45) |
|
| >.99 | |
| Amyloid PETj positivek, n | 0 | 15 | 8 |
|
| >.99 | |
|
| |||||||
|
| Forward digit span | 0.06 (–0.43 to 1.08) | 0.12 (–1.50 to 20.99) | –0.15 (–0.59 to 0.83) | .86 | >.99 | >.99 |
|
| Backward digit span | –0.16 (–0.55 to 1.19) | –0.82 (–1.66 to –0.03) | –0.13 (–1.07 to 0.80) |
| >.99 | 0.41 |
|
| |||||||
|
| K-BNTl | 0.27 (–1.90 to 0.86) | –0.92 (–2.52 to –0.08) | –2.60 (–3.38 to –1.61) |
|
| 0.15 |
|
| Calculation | 12 (12-12) | 10 (7-12) | 10 (8-12) |
|
| >.99 |
|
| |||||||
|
| RCFTm: copying | 0.55 (–0.70 to 0.93) | –1.72 (–7.61 to 0.00) | –1.02 (–7.78 to 0.12) |
|
| >.99 |
|
|
|
|
| ||||
|
| SVLTn: immediate recall | 0.83 (0.24-1.48) | –2.25 (–2.85 to –0.95) | –1.79 (–2.45 to –0.87) |
|
| >.99 |
|
| SVLT: delayed recall | 0.88 (0.34-1.22) | –2.96 (–3.18 to –2.53) | –2.51 (–2.74 to –2.09) |
|
|
|
|
| SVLT: recognition | 0.89 (0.61-1.10) | –2.23 (–3.93 to –1.94) | –2.66 (–3.26 to –1.51) |
|
| >.99 |
|
| RCFT: immediate recall | 0.86 (0.61-1.10) | –2.23 (–3.93 to –1.94) | –2.66 (–3.26 to –1.51) |
|
| >.99 |
|
| RCFT: delayed recall | 1.36 (0.05-1.76) | –2.11 (–2.55 to –1.82) | –2.17 (–2.45 to –1.65) |
|
| >.99 |
|
| RCFT: recognition | 1.01 (0.04-1.47) | –2.48 (–2.75 to –2.16) | –2.36 (–2.58 to –1.97) |
|
| .56 |
|
| |||||||
|
| COWATo animal | 0.23 (–0.30 to 0.98) | –2.21 (–3.14 to –1.89) | –2.36 (–2.96 to –1.17) |
|
| >.99 |
|
| COWAT supermarket | 0.23 (–0.78 to 1.00) | –1.60 (–2.06 to –1.32) | –1.73 (–1.99 to –1.04) |
|
| >.99 |
|
| COWAT phonemic | 0.70 (0.00-1.59) | –1.37 (–1.61 to –0.47) | –0.85 (–1.68 to 0.28) |
|
| >.99 |
|
| Stroop test: color | 0.56 (–0.17 to 1.03) | –3.22 (–3.89 to –0.75) | –1.93 (–2.86 to –0.48) |
|
| .66 |
|
| MMSEp | 29 (28-30) | 22 (15-25) | 20 (17-22) |
|
| >.99 |
|
| CDRq | 0.5 (0.5-0.5) | 1.0 (0.5-1.0) | 1.0 (0.75-1.0) |
|
| >.99 |
|
| CDR sum of box | 0.5 (0.5-0.75) | 5.0 (4.25-6.25) | 4.5 (4.0-8.5) |
|
| >.99 |
|
| GDSr | 1.0 (0.0-4.0) | 2.0 (1.0-5.0) | 1.0 (0.5-7.0) | >.99 | .71 | >.99 |
aNC: normal control.
bEOAD: early-onset Alzheimer disease.
cLOAD: late-onset Alzheimer disease.
dItalicization show significant differences at P<.05.
eAPOE4: apolipoprotein E4.
fAPOE4 was analyzed in 49 patients: 13 NCs, 16 patients with EOAD, and 20 patients with LOAD. Participants with one or more copies of the ε4 allele (ie, ε2/4, ε3/4, ε4/4) were considered as ε4 carriers.
gn=13.
hn=16.
in=20.
jPET: positron emission tomography.
kAmyloid PET was analyzed in 26 patients: 3 NCs, 15 patients with EOAD, and 8 patients with LOAD. Amyloid PET positivity was interpreted based on previously reported guidelines for each ligand.
lK-BNT: Korean version of the Boston naming test.
mRCFT: Rey-Osterrieth Complex Figure Test.
nSVLT: Seoul Verbal Learning Test.
oCOWAT: Controlled Oral Word Association Test.
pMMSE: Mini-Mental State Examination.
qCDR: clinical dementia rating.
rGDS: geriatric depression scale.
Raw copy scores for the original and simplified Rey-Osterrieth Complex Figure Tests.
| Types of copy scores | NCa (n=17) | EOADb (n=17) | LOADc (n=21) | Post hoc Bonferroni test ( | ||
|
|
|
|
| NC vs EOAD | NC vs LOAD | EOAD vs LOAD |
| Simplified RCFTd (0, 16; IQR) | 15.5 (15-16) | 12.5 (3.8-14.4) | 13 (7.8-15) |
|
| .69 |
| Original RCFT (0, 36; IQR) | 35 (33-35) | 28 (10-32) | 30 (8-31) |
|
| >.99 |
aNC: normal control.
bEOAD: early-onset Alzheimer disease.
cLOAD: late-onset Alzheimer disease.
dRCFT: Rey-Osterrieth Complex Figure Test.
eItalicization show significant differences at P<.001.
Figure 5Correlation between original and simplified Rey-Osterrieth Complex Figure Test (RCFT) scores. All participants performed both original and simplified RCFTs. The simplified RCFT was manually scored separately in terms of both accuracy and placement, and it complied with the Meyers and Meyers’ standardized scoring of the original RCFT. Raw scores ranging from 0.0 to 16.0 can be obtained. There was a significant linear relationship between the conventional and simplified RCFT scores (r=0.889; P<.001).
Figure 6Representative pseudocolored drawings for each group. Pseudocolored drawings of (A) normal control (NC) individuals, (B) patients with early-onset Alzheimer disease (EOAD), and (C) patients with late-onset Alzheimer disease (LOAD), who drew all the elements. (D) Patients with EOAD and (E) LOAD who failed to reproduce the stimulus image. The strokes were colored based on the order of the drawings.
Digital data of simplified Rey-Osterrieth Complex Figure Tests.
| Type of digital data analysis | NCa (n=11) | EOADb (n=11) | LOADc (n=16) | Post hoc Dunn-Šidák test ( | |||
|
|
|
|
| NC vs EOAD | NC vs LOAD | LOAD vs EOAD | |
|
|
|
|
| ||||
|
| Total number of strokes | 24 (7) | 26 (16) | 23 (4) | >.99 | >.99 | >.99 |
|
| Number of long strokes | 14 (4) | 18 (12) | 16 (4) | >.99 | >.99 | >.99 |
|
| Number of short strokes | 8 (1) | 9 (7) | 7 (3) | >.99 | >.99 | >.99 |
|
| Length of strokes (cm) | 4.58 (0.71) | 3.99 (1.48) | 3.50 (0.86) | .34 |
| .90 |
|
| First 5 stroke ratios | 0.91 (0.16) | 0.69 (0.23) | 0.68 (0.28) | .04 | .07 | >.99 |
|
| Speed of the longest stroke (cm/s) | 6.31 (1.86) | 4.41 (2.76) | 4.08 (1.41) | .09 |
| >.99 |
|
| Transition time (second) | 1.39 (0.60) | 2.95 (1.83) | 6.23 (7.54) |
|
| .97 |
|
| Elapsed time of 5 early long strokes (second) | 14.43 (4.62) | 34.86 (19.39) | 23.65 (14.16) |
|
| .32 |
|
|
|
|
| ||||
|
| Whole area (cm2) | 84.17 (10.88) | 108.51 (58.81) | 84.01 (33.93) | >.99 | >.99 | >.99 |
|
| Skeleton area (cm2) | 58.40 (8.79) | 56.34 (20.78) | 55.29 (18.93) | >.99 | >.99 | >.99 |
|
| Horizontal center of the whole area | 0.42 (0.31) | 0.25 (0.67) | –0.23 (0.40) | .60 |
| .11 |
|
| Vertical center of the whole area | –3.70 (0.69) | –1.22 (1.84) | –1.61 (2.36) |
|
| .79 |
|
| Horizontal position of center of mass | 0.28 (0.34) | 0.46 (0.64) | –0.35 (0.59) | .74 |
|
|
|
| Vertical position of center of mass | –3.96 (0.83) | –2.05 (1.68) | 1.90 (2.12) |
|
| .99 |
|
| Top edge of the whole area | 0.25 (0.62) | –3.98 (3.59) | 2.37 (3.23) |
| .19 | .24 |
|
| Bottom edge of the whole area | –7.64 (1.00) | –6.44 (1.97) | –5.59 (1.85) | .21 |
| .80 |
|
| Top edge of the skeleton area | –1.14 (0.62) | 0.89 (2.45) | 1.10 (3.46) |
|
| .95 |
|
| Bottom edge of the skeleton area | –7.64 (1.00) | –6.44 (1.97) | –5.59 (1.85) |
|
| >.99 |
|
| Ratio of input | 0.01 (0.02) | 0.25 (0.26) | 0.18 (0.27) |
| .12 | .61 |
|
|
|
|
| ||||
|
| Cross-correlation maximum value | 0.25 (0.02) | 0.19 (0.05) | 0.20 (0.04) |
|
| .86 |
|
| Size-rescaled cross-correlation maximum value | 0.14 (0.04) | 0.11 (0.05) | 0.09 (0.05) | .38 |
| .67 |
aNC: normal control.
bEOAD: early-onset Alzheimer disease.
cLOAD: late-onset Alzheimer disease.
dItalicization show significant differences at P<.05.